These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18948628)

  • 1. Overcoming an energy crisis?: an adaptive role of glycogen synthase kinase-3 inhibition in ischemia/reperfusion.
    Zhai P; Sadoshima J
    Circ Res; 2008 Oct; 103(9):910-3. PubMed ID: 18948628
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
    Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
    Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial adenine nucleotide transport and cardioprotection.
    Das S; Steenbergen C
    J Mol Cell Cardiol; 2012 Feb; 52(2):448-53. PubMed ID: 21945520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
    Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
    Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
    Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
    J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
    Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
    J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
    Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
    Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury.
    Imahashi K; Schneider MD; Steenbergen C; Murphy E
    Circ Res; 2004 Oct; 95(7):734-41. PubMed ID: 15345651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes.
    Fernandez-Sanz C; Ruiz-Meana M; Castellano J; Miro-Casas E; Nuñez E; Inserte J; Vázquez J; Garcia-Dorado D
    Thromb Haemost; 2015 Mar; 113(3):441-51. PubMed ID: 25631625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of GSK-3β with mitochondrial permeability transition pore modulators during preconditioning: age-associated differences.
    Zhu J; Rebecchi MJ; Glass PS; Brink PR; Liu L
    J Gerontol A Biol Sci Med Sci; 2013 Apr; 68(4):395-403. PubMed ID: 23070879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion.
    Gomez L; Paillard M; Thibault H; Derumeaux G; Ovize M
    Circulation; 2008 May; 117(21):2761-8. PubMed ID: 18490522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial apoptosis without VDAC.
    Galluzzi L; Kroemer G
    Nat Cell Biol; 2007 May; 9(5):487-9. PubMed ID: 17473857
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitochondrial permeability transition in the diabetic heart: contributions of thiol redox state and mitochondrial calcium to augmented reperfusion injury.
    Sloan RC; Moukdar F; Frasier CR; Patel HD; Bostian PA; Lust RM; Brown DA
    J Mol Cell Cardiol; 2012 May; 52(5):1009-18. PubMed ID: 22406429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload.
    Omar MA; Wang L; Clanachan AS
    Cardiovasc Res; 2010 Jun; 86(3):478-86. PubMed ID: 20053658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
    Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
    Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the mitochondrial membrane permeability transition in cell death.
    Tsujimoto Y; Shimizu S
    Apoptosis; 2007 May; 12(5):835-40. PubMed ID: 17136322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
    Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.